The Next Phase in the Management of the COVID-19 Pandemic A Discussion of Trade-Offs of Different Strategies

Main Article Content

James Douketis (ED)

COVID-19, pandemic


In the coming days and weeks, medical professionals can have an important role to discuss and debate different strategies and trade-offs in managing the next phase of the pandemic. Let us engage in this discussion in a vigorous, bidirectional, and candid manner to achieve a balanced way forward.

Abstract 282 | pdf English Downloads 85 pdf French Downloads 45 html english Downloads 41 html French Downloads 26


1. Graham BS. Rapid COVID-19 vaccine development. Science 2020;368:945-6. doi: 10.1126/science.abb8923. Epub 2020 May 8.
2. Lurie N, Saville M, Hatchett R, et al. Developing COVID-19 vaccines at pandemic speed. N Engl J Med 2020;382:1969–73. doi: 10.1056/ NEJMp2005630. Epub 2020 Mar 30.
3. Hanney SR, Wooding S, Sussex J, et al. From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider
lessons? Health Res Policy Syst 2020;18:61. doi: 10.1186/s12961-020-00571-3. 4. Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye
protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 2020;395:1973–87. doi: 10.1016/S0140-6736(20)31142-9.
5. Public Health Ontario. Daily Epidemiologic Summary. [Internet]. Available at:
6. Erikstrup C, Hother CE, Pedersen OBV, et al. Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors. Clin Infect Dis 2020 Jun 25:ciaa849. doi: 10.1093/cid/ciaa849.
7. Weinberger DM, Chen J, Cohen T, et al. Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020. JAMA Intern Med 2020; doi:10.1001/jamainternmed.2020.3391.
8. Woolf SH, Chapman DA, Sabo RT, et al. Excess deaths from COVID-19 and other causes, March-April 2020. JAMA 2020. doi:10.1001/jama.2020.11787.